Showing posts with label Heat Biologics. Show all posts
Showing posts with label Heat Biologics. Show all posts
Thursday, January 12, 2012
Heat Biologics: Vaccine biotech Heat Bio lands $250K; plans trials for bladder, ovarian cancers
"Heat (Biologics) is in phase 2 clinical trials studying its vaccine candidate HS-110 to treat non-small cell lung cancer. The company plans to start additional clinical studies in bladder and ovarian cancer this year."
Subscribe to:
Posts
(
Atom
)
